- 1 in 9 Canadian adults have experienced long-term COVID symptoms, StatsCan says

- Experiences of Canadians with long-term symptoms following COVID-19

- Self-copying RNA vaccine wins first full approval: what’s next?

- What's the optimal paxlovid protocol for a 36-year old who is completely healthy, no pre-existing conditions, and who tested positive for COVID ~3 days ago? I've read about alternate protocols where people take the 2 daily doses for the first day or 2, and then switch to 1 dose per day. Thoughts?

- 1 in 9 Canadian adults have had long-term symptoms from COVID infection: StatCan

- 'We're clearly in a wave:' Ontario's COVID-19 wastewater signal is more than double what it was at this time last year

- COVID-19 hospitalizations are increasing in US, rates are highest among oldest and youngest Americans

- 15 states seeing 'high' or 'very high' levels of respiratory illness: CDC

- Report spotlights inequalities in COVID vaccine access in poorer nations

- It's not just COVID anymore, or a triple-demic. Welcome to the 'new norm' of seasonal illnesses: Range of viral, bacterial infections are circulating while Canadian hospitals remain under strain

- Former Polish president Lech Walesa in hospital with covid-19

- Using both nose, throat swabs boosts sensitivity of rapid COVID testing

- Study shows infants exposed to COVID in utero at risk for developmental delay

- Home Test to Treat program extends nationwide: Program now offers testing, telehealth and treatment for COVID-19 and flu

- Inhibition of USP2 Prevents ACE2-Dependent Coronavirus Infection

- Covid study: mRNA vaccines could be fine-tuned

- Updated Novavax COVID-19 shot approved by Health Canada

- COVID inquiry: how it works, and when we will know if it is successful

- Erie County Health Department says to take preventive measures against COVID amid rise in cases and deaths

- Vulnerable Americans are going into the holiday season without COVID-19 protections

- German accused of founding armed group to fight COVID rules

- The lingering symptoms of post-COVID-19 condition (long-COVID): a prospective cohort study

- Dobrava hantavirus and coinciding SARS-CoV-2 infection mimicking thrombotic microangiopathy and responding to a single dose of eculizumab

- Small study finds brain alterations after COVID Omicron infection

- Slow COVID-19 booster rollout cost thousands of lives, new study says

Last updated Sat, 09 Dec 2023 23:35:20 GMT